MRVI Q4 2020 Earnings — Maravai LifeSciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

MRVIMaravai LifeSciences Holdings, Inc.

$999M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$98M+173.5% YoY

Gross Profit

$75M76.2% margin

Operating Income

$31M31.8% margin

Net Income

$13M13.3% margin

EPS (Diluted)

$0.22

QoQ Revenue Growth

+11.9%

Cash Flow

Operating Cash Flow

$79M

Free Cash Flow

$71M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.1B

Stockholders' Equity

$89M

Cash & Equivalents

$236M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$98M	$36M	+173.5%
Gross Profit	$75M	$18M	+313.4%
Operating Income	$31M	$1M	+2329.6%
Net Income	$13M	-$5M	+343.5%